The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: BMC Cancer 13 (2013) 286
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2013
- Creator
-
Kerl, Kornelius Tobias
Ries, David
Unland, Rebecca
Borchert, Christiane
Moreno, Natalia
Hasselblatt, Martin
Jürgens, Heribert
Kool, Marcel
Görlich, Dennis
Eveslage, Maria
Jung, Manfred
Meisterernst, Michael
Frühwald, Michael
- URN
-
urn:nbn:de:hbz:6-94309669593
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kerl, Kornelius Tobias
- Ries, David
- Unland, Rebecca
- Borchert, Christiane
- Moreno, Natalia
- Hasselblatt, Martin
- Jürgens, Heribert
- Kool, Marcel
- Görlich, Dennis
- Eveslage, Maria
- Jung, Manfred
- Meisterernst, Michael
- Frühwald, Michael
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2013
Other Objects (12)
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician